These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7550542)
1. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Després JP; Lemieux S; Lamarche B; Prud'homme D; Moorjani S; Brun LD; Gagné C; Lupien PJ Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S76-86. PubMed ID: 7550542 [No Abstract] [Full Text] [Related]
2. Visceral obesity, insulin resistance, and dyslipidemia: contribution of endurance exercise training to the treatment of the plurimetabolic syndrome. Després JP Exerc Sport Sci Rev; 1997; 25():271-300. PubMed ID: 9213095 [No Abstract] [Full Text] [Related]
3. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk. Després JP Obes Res; 1998 Apr; 6 Suppl 1():8S-17S. PubMed ID: 9569171 [TBL] [Abstract][Full Text] [Related]
4. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Chan JC; Tong PC; Critchley JA Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Qatanani M; Lazar MA Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046 [TBL] [Abstract][Full Text] [Related]
9. Adipose tissue: a mediator of cardiovascular risk. Sharma AM Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S5-7. PubMed ID: 12457291 [TBL] [Abstract][Full Text] [Related]
10. [Insulin resistance--possible causes and effects]. Bornkessel B Med Monatsschr Pharm; 1996 Mar; 19(3):81-4. PubMed ID: 8868967 [No Abstract] [Full Text] [Related]
11. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555 [TBL] [Abstract][Full Text] [Related]
12. The clinical implications of insulin resistance. Peters AL Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420 [TBL] [Abstract][Full Text] [Related]
13. The key role of insulin resistance in the cardiometabolic syndrome. Gill H; Mugo M; Whaley-Connell A; Stump C; Sowers JR Am J Med Sci; 2005 Dec; 330(6):290-4. PubMed ID: 16355013 [TBL] [Abstract][Full Text] [Related]
14. Insulin effect on adipose tissue (AT) adiponectin expression is regulated by the insulin resistance status of the patients. Hernandez-Morante JJ; Milagro FI; Lujan JA; Martinez JA; Zamora S; Garaulet M Clin Endocrinol (Oxf); 2008 Sep; 69(3):412-7. PubMed ID: 18208577 [TBL] [Abstract][Full Text] [Related]
15. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome]. Hashimoto N; Saito Y Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566 [TBL] [Abstract][Full Text] [Related]
16. Dyslipidaemia and obesity. Després JP Baillieres Clin Endocrinol Metab; 1994 Jul; 8(3):629-60. PubMed ID: 7980350 [TBL] [Abstract][Full Text] [Related]
17. Dyslipidemia of central obesity and insulin resistance. Brunzell JD; Hokanson JE Diabetes Care; 1999 Apr; 22 Suppl 3():C10-3. PubMed ID: 10189557 [No Abstract] [Full Text] [Related]
18. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy. Tankó LB; Christiansen C Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431 [TBL] [Abstract][Full Text] [Related]
19. Insulin resistance and hypertension in the absence of subcutaneous fat. Chaudhuri A; Izzo JL Rev Cardiovasc Med; 2000; 1(2):120-4. PubMed ID: 12457148 [TBL] [Abstract][Full Text] [Related]
20. The metabolic syndrome--from insulin resistance to obesity and diabetes. Gallagher EJ; Leroith D; Karnieli E Med Clin North Am; 2011 Sep; 95(5):855-73. PubMed ID: 21855696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]